Treatment of IC-BPS reaches new heights
Dr Sanjay Pandey, urologist, Kokilaben Dhirubhai Ambani Hospital says that awareness and early diagnosis, coupled with a…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Guest Blogs
Big Pharma is the New Big Tobacco
Anil Khanna, Partner, Wisdomsmith Advisors, writes about how the pharmaceutical industry is the west has overtaken the tobacco…
How to Deal with Antimicrobial Resistance in India
Akansh Khurana, CEO & Co-founder, THB, writes about the surge in antimicrobial resistance in India, misuse of antibiotics, and…
The smart prescription for pharma leaders to click
Mohan Joshi, Independent Management Consultant, writes about how latest digital technology has the potential to disrupt the…
Accelerating drug development at a lower cost: How adopting AI can transform the pharma industry
To combat the complex drug discovery process, medical industry is organising steps to adapt the futuristic technologies like AI to…
We are still far from cure of HIV/AIDS
An HIV patient has to take medicines lifelong without any break and cannot afford to miss even five per cent of the prescribed…
“The Golden Days Are Here Again” –Clinical Trial Market of India in 2019 and onwards
Dr Siddharth Dutta, Senior Healthcare Advisor opines on how the general elections will impact the healthcare industry for the…
Home in on talent, wherever in the world
Mohan Joshi, Independent Management Consultant, writes about how the contemporary leader can, and should, connect across and…
Regulations for pharma ingredients in India – Too much hope from a complex market in 2019
Active Pharmaceutical Ingredient production in India, though a rapidly expanding industry, still faces a lot of competition form…
Special 301 Report 2019: A Deliberate attempt to weaken India’s Patents Act and to tarnish…
The US allegation on threat of exercise of compulsory license by India shows lack of appreciation of the US for multilateral rules…